Rolke James bought REVB
October 29, 2025 · Form 4 insider transaction
Rolke James bought 390,614 shares of Revelation Biosciences, Inc. at $1.28 per share, a transaction worth $500.0K. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
390,614
Price
$1.28
Total value
$500.0K
InsiderRolke James
RoleOfficer, Director
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateOctober 29, 2025
Filing dateOctober 31, 2025
Shares owned after400,660
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Restricted Stock Grant under the 2021 Equity Incentive Plan. Vests quarterly over one year from the grant date.